Month: March 2021

STAMFORD, Conn., March 29, 2021 (GLOBE NEWSWIRE) — Eagle Bulk Shipping Inc. (NASDAQ: EGLE) (“Eagle Bulk”, “Eagle” or the “Company”), one of the world’s largest owner-operators within the Supramax / Ultramax drybulk segment, today announced that Gary Vogel, the Company’s Chief Executive Officer will participate in a Bloomberg Intelligence Webinar titled “Will Dry Bulk Finally Deliver?” on April 1, 2021 at 10:30 AM Eastern Time. During the 1-hour webinar, which will be hosted by Lee Klaskow, Senior Analyst, Bloomberg Intelligence, Mr. Vogel will discuss the current dynamics in the drybulk shipping market, Eagle Bulk’s strategy and competitive positioning and the prospects for continued market strength throughout 2021 and beyond. The webinar will be broadcast live and available for on-demand replay. It can accessed through a Bloomberg...

NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the completion of the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) requesting approval of ublituximab, the Company’s investigational glycoengineered anti-CD20 monoclonal antibody, in combination with UKONIQTM (umbralisib) , the Company’s once-daily, oral, inhibitor of PI3K-delta and CK1-epsilon, as a treatment for patients with chronic lymphocytic leukemia (CLL). The U.S. FDA previously granted Fast Track designation to the combination of ublituximab and umbralisib (U2) for the treatment of adult patients with CLL and orphan drug designation for ublituximab in combination with umbralisib for the treatment of CLL. The BLA submission was based on the results of the UNITY-CLL...

The transaction reduces leverage, accelerates recurring fee income, and expands a key institutional partnership TORONTO, March 29, 2021 (GLOBE NEWSWIRE) — WPT Industrial Real Estate Investment Trust (the “REIT”) (TSX: WIR.U; WIR.UN; OTCQX: WPTIF) announced today that it will contribute a portfolio of 13 U.S. distribution and logistics properties (the “Portfolio”) with a value of approximately $370 million into a newly established joint venture with the Investment Management Corporation of Ontario (the “Joint Venture”).  All dollar amounts are stated in U.S. funds. Completion of the Joint Venture advances the REIT’s previously announced capital recycling initiative, while reducing overall leverage and increasing liquidity. The REIT will retain a majority ownership interest in the Portfolio and continue to manage and operate...

TORONTO, March 29, 2021 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce that the TSX Venture Exchange (the “TSXV”) has accepted for listing 19,046,875 common share purchase warrants of the Company (the “Warrants”) issued in connection with the Company’s previously announced bought deal short-form prospectus offering of units. The TSXV has advised that these Warrants will be listed for trading on the TSXV under the symbol “WMD.WT” effective at market open on March 30, 2021. Each Warrant entitles the holder thereof to purchase one common share of the Company (a “Common Share”) at an exercise price of $0.60 per Common Share until March 12, 2023. If after March 12, 2022 the daily volume weighted...

·       Automation solution increases processing capacity to 6,000 PCR tests per day, expandable to 12,000 daily tests with minor upgrades ·       Client entered into contract with the State of Kentucky to provide PCR testing for nursing home facilities NEW YORK, NY, and REHOVAT, ISRAEL, March 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire —Todos Medical, Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening, diagnosis and immune support, as well as developing blood tests for early detection of cancer and Alzheimer’s disease, today announced the successful installation of automated lab equipment and completion of training for a lab client in Brooklyn, NY. The implementation of the Todos automation solution has expanded the lab’s processing capacity to 6,000...

VANCOUVER, British Columbia, March 29, 2021 (GLOBE NEWSWIRE) — Photon Control Inc. (“Photon Control” or the “Company”) (TSX: PHO), a leading manufacturer of fiber optic measurement solutions, is pleased to announce its recently acquired business, Micronor LLC (“Micronor”), was recognized for its critical contribution to the International Thermonuclear Experimental Reactor (“ITER”), one of the most ambitious energy projects in the world today. The project aims to demonstrate magnetic fusion as a large scale and carbon-free source of energy to advance the science for future fusion power plants. Micronor is one of the many technology companies collaborating with Fusion For Energy (F4E), the European Union organization managing Europe’s contribution to ITER. Micronor’s innovative technology and engineering expertise was required to...

TORONTO and KNOXVILLE, Tenn., March 29, 2021 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR) is pleased to report significant progress at both the project and corporate levels of the Company as it enters the second quarter with a record pipeline of projects and a strong balance sheet to support future growth. Solar Alliance has built a strong backlog of projects under various stages of agreement with combined capital costs totaling approximately US $66 million, consisting of a diversified portfolio of customers and project sizes. The Company continues to build out that backlog of project opportunities by focusing on the high margin sectors of the solar industry – residential developers and builders, commercial clients, microgrid solutions for larger clients and large scale project...

DURHAM, N.C., March 29, 2021 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its ARCUS® genome editing platform, today announced it will participate in the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Day on April 1, 2021. Details for the presentation are below: Guggenheim Healthcare Talks | 2021 Genomic Medicines & Rare Disease DayPanel: On the Cusp of Genomic Medicine and Cell Therapy for Dyslipidemia and T1DMPresenter: Derek Jantz, Ph.D., Chief Scientific OfficerDate: Thursday, April 1, 2021Time: 8:00-8:50 AM ET A live webcast of the presentation will be accessible on the Company’s website, www.precisionbiosciences.com, in the Investors & Media section under Events and...

TORONTO, March 29, 2021 (GLOBE NEWSWIRE) — U3O8 Corp. (NEX: UWE.H) (“U3O8” or the “Company”) announces that it has commenced staged test work to determine the efficiency of membranes to recover battery commodities from its Berlin Deposit in Colombia. The objective of the test work is to determine the cost-effectiveness of membrane separation to concentrate battery commodities such as nickel, vanadium and phosphate, among others, as well as uranium, after they have been leached from the mineralized host-rock. Basic Membrane TechnologyMembranes operate like molecular sieves, allowing small molecules to pass through, while retaining larger molecules. The size of molecules that can pass through the membrane is determined by the pore size of the membrane. In potable water production, the general concept is that dirty water is pumped...

SALT LAKE CITY, March 29, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Eric Santa as its new Chief Growth Officer. In this role, he will be responsible for accelerating growth initiatives and building commercial capabilities, and digital platforms to better serve patients and healthcare providers, while driving increased market demand for the company’s portfolio of existing and new products and services. Santa, who reports directly to Paul J. Diaz, president and CEO of Myriad Genetics, brings proven healthcare expertise spanning consumer and digital businesses, as well as commercial transformation, portfolio management, and new growth channels. He previously served as Chief Revenue Officer of Rally Health, Inc., a division of Optum within UnitedHealth...